Vanderwalde, A.M.
~ 100  results:
Search for persons X
?
1

Safety and Efficacy of RP1 + Nivolumab in Patients with Non..:

Niu, J. ; Milhem, M. ; Vanderwalde, A.M....
International Journal of Radiation Oncology*Biology*Physics.  112 (2022)  5 - p. e8-e9 , 2022
 
?
2

SP-008: Concert Randomised Trials with Panitumumab:

Giralt, J. ; Mesia, R. ; Trigo, J.M....
Radiotherapy and Oncology.  106 (2013)  - p. S3 , 2013
 
?
6

Characterization of KRAS Mutation Subtypes in Non–small Cel..:

Judd, Julia ; Abdel Karim, Nagla ; Khan, Hina...
Molecular Cancer Therapeutics.  20 (2021)  12 - p. 2577-2584 , 2021
 
?
8

P1.12-08 Characterization of MET Exon 14 Skipping Analog (Y..:

Kim, S.Y. ; Narvel, H.G. ; Gandhi, N....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S210-S211 , 2023
 
?
9

EP03.01-02 Molecular Characterization of Non-small Cell Lun..:

Aggarwal, V. ; Xiu, J. ; Nagasaka, M....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S439-S440 , 2023
 
?
12

24LBA Safety data from the phase 1b part of the MASTERKEY-2..:

Long, G.V. ; Dummer, R. ; Ribas, A....
European Journal of Cancer.  51 (2015)  - p. S722 , 2015
 
?
13

Long-Term Survival after High-Dose Chemotherapy Followed by..:

VanderWalde, A. ; Ye, W. ; Frankel, P....
Biology of Blood and Marrow Transplantation.  18 (2012)  8 - p. 1273-1280 , 2012
 
?
14

Impact of gender and mutational differences in hormone rece..:

Robert Hsu ; Denaly Chen ; Bing Xia...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1215524/full.  , 2023
 
1-15